Citation

Koike Y, Akibayashi M, Yokouchi Y. Int. J. Adolesc. Med. Health 2017; 29(4).

Copyright

(Copyright © 2017, Freund Publishing)

DOI

10.1515/ijamh-2015-0071

PMID

unavailable

Abstract

A 19-year-old woman visited our outpatient clinic requesting treatment for short stature. She had been repeatedly hospitalized at a psychiatric unit and was subsequently diagnosed with anorexia nervosa (AN). She was 139.3 cm (-3.6 SD) tall and weighed 25.5 kg (23% lower than standard weight). She had primary amenorrhea and her bone age (BA) was 11.8 years. She had low insulin-like growth factor (IGF)-I (80 ng/mL) and a basal growth hormone (GH) level of 1.47 ng/mL. Treatment with recombinant GH was initiated. At 22 years of age, she was 152.2 cm (-1.1 SD) tall and weighed 39.7 kg. As she had shown a favorable response to GH treatment, therapy was discontinued. We suggest that it is worthwhile treating AN patients with GH replacement therapy for short stature, once low IGF-I levels without GH resistance, delayed puberty, delay in BA, and nutritional stabilization are taken into consideration. © 2017 Walter de Gruyter GmbH, Berlin/Boston.

Language: en

Keywords

bone age; delayed puberty; growth hormone resistance; IGF-I; nutrition